HRA005455
Title:
Decoupling acquired and intrinsic chemotherapy resistance from longitudinal sequencing in colorectal liver metastases
Release date:
2024-06-07
Description:
Our team focused on the CRLM population receiving BVZ combined with chemotherapy as the first-line standard treatment, and initially explored the precision treatment of tumor resistance based on the genome and transcriptome sequencing of 49 matched samples obtained from multi-time nodes before and after treatment. Meanwhile, we demonstrate the underlying mechanisms of primary drug resistance mediated by SMAD4R361H missense mutations and secondary drug resistance under hepatocyte/myeloid cell interaction, which provided an analytical template and practical clinical basis for the accurate stratification as well as novel combined strategies of the first-line treatment in CRLM.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
colorectal cancer
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
NFHZLK_DAC
Contact person:
Liao Wangjun
Email:
liaowj@smu.edu.cn
Description:
RNA-seq data from the Department of Oncology, Nanfang Hospital.
Individuals & samples
Submitter:   Liao Wangjun / liaowj@smu.edu.cn
Organization:   Nanfang Hospital, Southern Medical University
Submission date:   2023-08-25
Requests:   3